Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis

PURPOSE: To assess the efficacy and safety of aripiprazole once-monthly 400 mg (AOM 400), an extended-release injectable suspension of aripiprazole, in obese and nonobese patients. PATIENTS AND METHODS: This post hoc analysis of a 38-week randomized, double-blind, active-controlled, noninferiority s...

Descripción completa

Detalles Bibliográficos
Autores principales: De Hert, Marc, Eramo, Anna, Landsberg, Wally, Kostic, Dusan, Tsai, Lan-Feng, Baker, Ross A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455850/
https://www.ncbi.nlm.nih.gov/pubmed/26064048
http://dx.doi.org/10.2147/NDT.S80479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455850/
https://www.ncbi.nlm.nih.gov/pubmed/26064048
http://dx.doi.org/10.2147/NDT.S80479

Ejemplares similares